COVID-19: Singapore manufacturer of medical diagnostic tools seeking European partners via distribution service agreement

The Singapore company is at the forefront of producing diagnostic products to detect illnesses in the human body. The company provides a range of products from test kits to other diagnostic tools. One of the products is the Covid-19 quantitative polymerise chain reaction (PCR) test kit. The kit provides all necessary reagents for the in vitro qualitative detection of the SARS-CoV-2 virus from respiratory. This test identifies the RNA of the SARS-CoV-2 virus isolated from infected patient samples using the quantitative PCR. Another test kit is the Covid-19 digital PCR kit. Digital PCR, being more sensitive and precise, may improve the detection of the virus especially when the viral load is low, which may be the case for early infections or recovering patients. Another product is the epstein-barr virus (EBV) quantification kit. The kit is developed for sensitive detection and quantification of EBV DNA using digital PCR system. Another product is the hepatitis B virus (HBV) quantification kit. The HBV quantification kit is developed for sensitive and precise quantification of HBV DNA from human blood samples. The company also produces products that aid the testing such as tube-strip, which can contain 8 reactions per tube-strip. Autoloader allows users to easily load PCR samples onto the disposable sample loading kit. Another product is the sealing enhancer, which job is to seal partitions to eliminate cross-contamination. Lastly, the reader works with tube strips to produce reactions of 4 tube-strips or 32 reactions. Due to expansion, the company is looking for European partners via a distribution service agreement.